We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02317991
Title Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer
Recruitment Completed
Gender
Phase Phase II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications
Therapies
Age Groups:
Covered Countries USA

Facility Status City State Zip Country Details
Rocky Mountain Cancer Centers Denver Colorado 80218 United States Details
Florida Cancer Specialists-South Fort Myers Florida 33916 United States Details
Florida Hospital Cancer Institute Orlando Florida 32804 United States Details
Florida Cancer Specialists-North Saint Petersburg Florida 33705 United States Details
Ingalls Cancer Research Center Harvey Illinois 60425 United States Details
Research Medical Center Kansas City Missouri 64132 United States Details
Oncology Hematology Care Cincinnati Ohio 45242 United States Details
Spartanburg Medical Center/Gibbs Cancer Center Spartanburg South Carolina 29303 United States Details
Tennessee Oncology Chattanooga Tennessee 37404 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
Center for Cancer and Blood Disorders Fort Worth Texas 76104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field